Incyte Presents New Oncology Data at ESMO Congress
Bitget2026/10/18 22:05- Incyte will present oncology data at the European Society for Medical Oncology Congress in Madrid on Oct. 23-27, 2026.
- Presentations will feature INCB161734, a KRAS G12D inhibitor, and INCA33890, a bispecific antibody; both are in ongoing Phase 3 programs.
- An investor event and webcast on Oct. 26, 2026, from 2:30-4:00 p.m. ET will cover key data and portfolio updates.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cardano vs Solana: Analysts and ADA Holders Clash Over Adoption

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share
Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.


Bitcoin rebounds sharply from oversold levels, briefly surpassing $57,000
